Seborrheic dermatitis of scalp Seborrheic dermatitis of scalp, mometasone lotion, Elomet lotion
Conditions
Interventions
Mometasone furoate 0.1% w/w (manufactured by HOE Pharmaceuticals Sdn. Bhd.), lotion, apply few drops on lesion at scalp, for 4 weeks
,Mometasone furoate 0.1% w/w (manufactured by Schering-Plough Labo
Experimental Drug,Active Comparator Drug
Mometasone lotion(Elosone),Elomet lotion
Sponsors
HOE Pharmaceuticals Sdn. Bhd.
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-80 years 2. Diagnosed with seborrheic dermatitis of scalp 3. New onset dermatitis or recurrent seborrheic dermatitis in which can withdraw topical steroid and Moisturizer for 2 weeks, oral medication for 4 weeks before joining this project 4.No other medications usage during the project 5.Can follow up at 2nd and 4th week of the project 6. Inform and consent
Exclusion criteria
Exclusion criteria: 1. History of allergic reaction to component used in the project 2. Ongoing bacterial, fungal or viral skin infection 3. Pregnancy or breastfeeding 4. History of allergic reaction to topical or systemic steroid 5. Deny or withdraw during attending the project
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical severity of seborrheic dermatitis of scalp 2nd and 4th week after using mometasone lotion Modified clinical severity score | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Satisfaction Score, side effect of lotion 2nd and 4th week after using mometasone lotion Patient reported outcome using a visual analogue scale and note the side effect | — |
Countries
Thailand
Contacts
Public ContactMontree Udompataikul
Srinakharinwirot University
Outcome results
None listed